Who owns RLAY? 13F holders and whale ownership
RLAY is tracked across public portfolios in Whale Analyzer. This page answers who owns RLAY, which top funds are buying RLAY, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $97.0M | 9.8M | Increased |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $11.5M | 1.2M | Held |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- PRAX whale holders — PRAXIS PRECISION MEDICINES I
- CELC whale holders — CELCUITY INC
- ASND whale holders — ASCENDIS PHARMA A/S
- ROIV whale holders — ROIVANT SCIENCES LTD
- CNTA whale holders — CENTESSA PHARMACEUTICALS PLC
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- SYRE whale holders — SPYRE THERAPEUTICS INC
- NUVL whale holders — NUVALENT INC
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns RLAY stock?
Whale Analyzer tracks 2 public institutional holders of RLAY with a combined reported value of $108.6M. See the holder table above for the largest tracked positions.
Which top funds are buying RLAY?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for RLAY?
Use the interactive RLAY dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.